CRISPR-X Trademark

Trademark Overview


On Tuesday, October 31, 2023, a trademark application was filed for CRISPR-X with the United States Patent and Trademark Office. The USPTO has given the CRISPR-X trademark a serial number of 98247548. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, December 16, 2024. This trademark is owned by CRISPR Therapeutics AG. The CRISPR-X trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research and development, namely, gene editing for researching and developing human cells and pharmaceuticals; research and development of therapeutics pharmaceuticals using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development, namely, providing medical and scientific research and development in the fields of pharmaceuticals and biopharmaceuticals; medical research laboratory services; scientific laboratory services; custom cell-line engineering services for scientific research purposes; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, t...

General Information


Serial Number98247548
Word MarkCRISPR-X
Filing DateTuesday, October 31, 2023
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateMonday, December 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 7, 2025

Trademark Statements


Description of MarkThe mark consists of the stylized wording "CRISPR-X", with the "X" being formed with curved edges ending in a point with three horizontal lines between the top two arms of the "X" and three horizontal lines between the bottom two arms of the "X".
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesScientific research and development, namely, gene editing for researching and developing human cells and pharmaceuticals; research and development of therapeutics pharmaceuticals using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development, namely, providing medical and scientific research and development in the fields of pharmaceuticals and biopharmaceuticals; medical research laboratory services; scientific laboratory services; custom cell-line engineering services for scientific research purposes; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting genetic therapies to individuals

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, November 8, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCRISPR Therapeutics AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressZUG V8 6300
CH

Trademark Events


Event DateEvent Description
Friday, November 3, 2023NEW APPLICATION ENTERED
Wednesday, November 8, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 9, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, May 1, 2024ASSIGNED TO EXAMINER
Thursday, May 9, 2024NON-FINAL ACTION WRITTEN
Thursday, May 9, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 8, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 8, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 8, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 9, 2024NON-FINAL ACTION E-MAILED
Tuesday, December 10, 2024APPROVED FOR PUB - PRINCIPAL REGISTER